Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №3 (2024) > Recurrent pelvic organ prolapse: from epidemiology and risk factors to modern options for early verification

Recurrent pelvic organ prolapse: from epidemiology and risk factors to modern options for early verification

Mekan R. Orazov , Viktor E. Radzinsky , Farida F. Minnullina , Evgeny D. Dolgov

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Currently, crystallization and strengthening of some demographic paradoxes are observed. The progressive birth rate decrease and the population increase seemed to be mutually exclusive processes until today. Recurrent pelvic organ prolapse, that significantly decreases the patient’ quality of life regardless of the age, represents one of the unsolved problems of modern gynecology. Given this fact, the paper is aimed to discuss the relevance of this issue at present, as well as to describe the advanced verification algorithms of the structural defects associated with recurrent genital prolapse in order to predict progression of the disease at a very early stage.
Keywords: recurrent genital prolapse, risk factors, early diagnosis of genital prolapse recurrence.


About the Author

Mekan R. Orazov 1 , Viktor E. Radzinsky 1 , Farida F. Minnullina 2 , Evgeny D. Dolgov 1

1 People’s Friendship University of Russia (RUDN University), Moscow, Russia;

2 Kazan (Volga region) Federal University, Kazan, Russia; City Clinical Hospital No. 7 named after M.N. Sadykov, Kazan, Russia

References

1. Barba M et al. How Old Is Too Old? Outcomes of Prolapse Native-Tissue Repair through Uterosacral Suspension in Octogenarians. Life. 2024;14(4):433.
2. Оразов М.Р., Долгов Е.Д. Неизбежное старение или успешное взросление? Anti-ageing-медицина: конкретно об абстрактном. Клинический разбор в общей медицине. 2023;4(3):67-76. DOI: 10.47407/kr2023.4.3.00226 Orazov M.R., Dolgov E.D. Inevitable aging or successful maturation? Anti-aging medicine: specifically about the abstract. Clinical review for general practice. 2023;4(3):67-76. DOI: 10.47407/kr2023.4.3.00226 (in Russian). 
3. Iglesia CB, Smithling KR. Pelvic organ prolapse. American Family Physician. 2017;96(3):179-85.
4. Fleischer K, Thiagamoorthy G. Pelvic organ prolapse management. Post Reproductive Health. 2020;26(2):79-85.
5. Wu JM, Matthews CA, Conover MM et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstetrics & Gynecology. 2014;123(6):1201-6.
6. Denman MA, Gregory WT, Boyles SH et al. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. American Journal of Obstetrics and Gynecology. 2008;198(5):555-e1.
7. Carroll L, O’Sullivan C, Doody C et al. Pelvic organ prolapse: The lived experience. Plos one. 2022;17(11): p.e0276788.
8. Abduraimovna AF, Komilovna SG, Yusufjanovich EU, Rafiqovich ZA. Evaluation of the effectiveness of physical activity in pelvic organ prolapse. In: E Conference Zone. 2023;(2):42-8.
9. Weintraub AY, Glinter H, Marcus-Braun N. Narrative Review of the Epidemiology, Diagnosis and Pathophysiology of Pelvic Organ Prolapse. International Braz J Urol. 2020;46(1):5-14.
10. Roos EJ, Schuit E. Timing of recurrence after surgery in pelvic organ prolapse. International Urogynecology Journal. 2021;32:2169-76.
11. Pang H, Zhang L, Han S et al. A nationwide population‐based survey on the prevalence and risk factors of symptomatic pelvic organ prolapse in adult women in China – a pelvic organ prolapse quantification system‐based study. BJOG: An International Journal of Obstetrics & Gynaecology, 2021;128(8):1313-23.
12. Jady HF et al. Understanding pelvic organ prolapse: causes, symptoms, and risk factors. European Journal of Modern Medicine and Practice.2024. 4(1):10-9.
13. Fitz FF, Bortolini MAT, Pereira GMV et al. PEOPLE: lifestyle and comorbidities as risk factors for pelvic organ prolapse – a systematic review and meta-analysis PEOPLE: PElvic Organ Prolapse Lifestyle comorbiditiEs. International Urogynecology Journal. 2023;34(9):2007-32.
14. Shi W, Guo L. Risk factors for the recurrence of pelvic organ prolapse: a meta-analysis. Journal of Obstetrics and Gynaecology. 2023;43(1):2160929.
15. Schulten SF, Detollenaere RJ, IntHout J et al. Risk factors for pelvic organ prolapse recurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension. American Journal of Obstetrics and Gynecology. 2022;227(2):252-e1.
16. Mattsson NK, Karjalainen PK, Tolppanen AM et al.  Pelvic organ prolapse surgery and quality of life – a nationwide cohort study. American journal of obstetrics and gynecology. 2020;222(6):588-e1.
17. Tefera Z, Temesgen B, Arega M et al. Quality of life and its associated factors among women diagnosed with pelvic organ prolapse in Gynecology outpatient department Southern Nations, Nationalities, and Peoples region public referral hospitals, Ethiopia. BMC Women's Health. 2023;23(1):342.
18. Peinado Molina RA, Hernández Martínez A, Martínez Vázquez S, Martínez Galiano JM. Influence of pelvic floor disorders on quality of life in women. Frontiers in Public Health. 2023;(11):1180907.
19. Ismail S et al. Recurrent pelvic organ prolapse: International Urogynecological Association research and development committee opinion. International Urogynecology Journal. 2016;27:1619-32.
20. Studer AM, Faehnle-Schiegg I, Frey J et al.  Recurrent Pelvic Organ Prolapse after Sacrocolpopexy – A Surgical Challenge. Journal of Clinical Medicine. 2024;13(6):613.
21. Ghafoor S, Beintner-Skawran S, Betschart C et al. Assessment of pelvic organ prolapse with the Pelvic Inclination Correction System: defining the normal range and threshold to pathology. Abdom Radiol. 2024. DOI: 10.1007/s00261-024-04222-x

For citation:Orazov M.R., Radzinsky V.E., Minnullina F.F., Dolgov E.D. Recurrent pelvic organ prolapse: from epidemiology and risk factors to modern options for early verification. Clinical review for general practice. 2024; 5 (3): 63–67. (In Russ.). DOI: 10.47407/kr2023.5.3.00374


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru